Literature DB >> 19374519

Predicting potentially functional SNPs in drug-response genes.

Grace S Y Pang1, Jingbo Wang, Zihua Wang, Caroline G L Lee.   

Abstract

SNPs are known to contribute to variations in drug response and there are more than 14 million polymorphisms spanning the human genome. However, not all of these SNPs are functional. It would be impractical and costly to evaluate every individual SNP for functionality experimentally. Consequently, one of the major challenges for researchers has been to seek out functional SNPs from all the SNPs in the human genome. In silico or bioinformatic methods are economical, less labor intensive, yet powerful approaches to filter out potentially functional SNPs in drug-response genes for further study. This allows researchers to prioritize which SNPs to subsequently evaluate experimentally for drug-response studies, as well as potentially providing insights into possible mechanisms underlying how SNPs may affect drug-response genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374519     DOI: 10.2217/pgs.09.12

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  9 in total

1.  Knowledge of Pharmacogenetics among Healthcare Professionals and Faculty Members of Health Training Institutions in Ghana.

Authors:  W Kudzi; B S Addy; B Dzudzor
Journal:  Ghana Med J       Date:  2015-03

2.  A novel genotyping method for detection of the CRHR1 (rs1396862: C>T) gene variation among North Indian population.

Authors:  Neeraj Sharma; Shally Awasthi; Subha R Phadke
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

Review 3.  Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application.

Authors:  Jiye Yin; Jianting Zhang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-10

4.  Discovery and functional assessment of gene variants in the vascular endothelial growth factor pathway.

Authors:  Laia Paré-Brunet; Dylan Glubb; Patrick Evans; Antoni Berenguer-Llergo; Amy S Etheridge; Andrew D Skol; Anna Di Rienzo; Shiwei Duan; Eric R Gamazon; Federico Innocenti
Journal:  Hum Mutat       Date:  2013-11-27       Impact factor: 4.878

5.  A novel catechol-O-methyltransferase variant associated with human disc degeneration.

Authors:  Helen E Gruber; Wei Sha; Cory R Brouwer; Nury Steuerwald; Gretchen L Hoelscher; Edward N Hanley
Journal:  Int J Med Sci       Date:  2014-05-15       Impact factor: 3.738

6.  The SNPs in pre-miRNA are related to the response of capecitabine-based therapy in advanced colon cancer patients.

Authors:  Yong Mao; Chengda Zou; Fanyi Meng; Jiehong Kong; Weipeng Wang; Dong Hua
Journal:  Oncotarget       Date:  2017-12-11

Review 7.  Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity.

Authors:  Chengyi Tu; Nathan J Cunningham; Mao Zhang; Joseph C Wu
Journal:  Front Pharmacol       Date:  2021-03-10       Impact factor: 5.810

8.  Gene Co-Expression Analysis Predicts Genetic Variants Associated with Drug Responsiveness in Lung Cancer.

Authors:  Sanaya Shroff; Jie Zhang; Kun Huang
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2016-07-20

9.  Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants.

Authors:  Hannah McConnell; T Daniel Andrews; Matt A Field
Journal:  PeerJ       Date:  2021-07-15       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.